Status:
UNKNOWN
Caffeine Consumption and Cataract Prevention
Lead Sponsor:
Vienna Institute for Research in Ocular Surgery
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Brief Summary
Effect of peroral caffeine consumption on the delay of cataract onset.
Detailed Description
Several experimental studies have shown that caffeine inhibits cataract development by scavenging reactive oxygen species. Evidence from epidemiological studies, however, is controversial. Varma et al...
Eligibility Criteria
Inclusion
- age older than 21 years
- cataract
Exclusion
- \- age younger than 21 years
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT05194696
Start Date
September 1 2020
End Date
September 1 2025
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria, 1140